Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Yeah. When I bought these shares I'd not envisaged selling them at this point, and I suppose nothing has really changed in that regard. Yes, I'd expected them to have ticked up rather than down after the MHRA approval, and de-listing massively restricts buying/selling, but again - I was planning on holding onto these for a few more years anyway, so hopefully following a triumphant return to the market with a £10 share price :D
Yes, it is undervalued by the market (hell - that's why we're all here...) but this has come out of leftfield. Surely a decision to delist isn't something that is agreed to in the Tuesday morning huddle following the bank holiday weekend. They must have been contemplating this for some time. Which makes the February share reissue seem a little shortsighted.
...from Clarissa's "Today is a very good day!" tweet following the (eventual) approval from the MHRA. Since then, the share price has done nothing but steadily decline to less than 10% of what it was at that point. Not sure that shafting them for the remaining 10% will engender much goodwill.
OCTP could find a cure for cancer, HIV and dementia; invent a 100% efficient and clean power source; create a self propagating and flood, drought and disease resistant crop that could end world hunger...
...and their share price would still fall on the news.
I'm grateful for the explanation, but still have questions. Some of the resolutions being voted on suggest (to my untrained eye) to grant the directors more power over the deferred shares than I would be comfortable with.
Right. So, my reading of it is that they take your shares and split them in two - with one being valued at 0.1p, and the other being valued at 0.9p.
They then wave a magic wand and turn the value of your 0.9p share into nothing.
The company's share value is then 0.1p. Market cap has then gone from around £9m to £900k (which ties in with the blurb in resolution 10 about issuing up to 66% of the issued share capital, or around £600k).
By all means shoot me down in flames, but this is how I read it.
Makes a mockery of their intentions with this doesn't it - https://www.gov.uk/government/consultations/consultation-on-proposals-for-legislative-changes-for-clinical-trials
They can't even manage their current timelines